MHRA Modernises Medicine Information Delivery
Summary
The MHRA has launched a project to modernise how medicines product information is delivered to patients, aiming for greater accessibility and trust. This initiative includes research into the role of patient information leaflets.
What changed
The Medicines and Healthcare products Regulatory Agency (MHRA) has initiated the 'Improving Patient Information' project, which seeks to update the delivery methods for medicines product information. The project's goal is to make this information more accessible, reliable, and prepared for future needs, with a stated commitment to an inclusive approach for all patients.
This initiative is primarily informational at this stage, focusing on modernising delivery rather than imposing new regulatory requirements. Regulated entities, such as drug manufacturers and healthcare providers, should be aware of this strategic direction from the MHRA, which aims to enhance patient understanding and engagement with their medications. No immediate compliance actions or deadlines are specified, but the project signals a future focus on improved patient information standards.
Source document (simplified)
Regulation
Improving Patient Information
MHRA's Improving Patient Information project aims to modernise how medicines product information is delivered, making it more accessible, trusted, and future-ready.
From: Medicines and Healthcare products Regulatory Agency Published 18 March 2026 Get emails about this page
Documents
Improving Patient Information
HTML
Research on the Role of Patient Information Leaflets in Meeting the Information Needs of Patients
PDF, 1.82 MB, 80 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
Your health decisions matter. The information you receive about your medicines should be clear, accessible, and support informed conversations between you and your healthcare professional. The MHRA is committed to leading a fully inclusive approach to improving medicines information for everyone.
Updates to this page
Published 18 March 2026
Sign up for emails or print this page
Get emails about this page Print this page
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when MHRA Guidance & Safety publishes new changes.